New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "eSMO Open-Cancer Horizons" Series

Matteo Lambertini, Matthias Preusser, Christoph C. Zielinski

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Article numbere000501
JournalESMO Open
Volume4
DOIs
Publication statusPublished - Jun 1 2019

Keywords

  • immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this